Lv3
345 积分 2021-06-16 加入
Neoadjuvant Immunochemotherapy for Stage II-IIIB Non-Small Cell Lung Cancer With Mutations Beyond EGFR 19del, L858R, and ALK Rearrangement
3天前
已完结
Updates on the treatment of epidermal growth factor receptor-mutant non–small cell lung cancer
3天前
已完结
Uncommon de novo EGFRT790M-Mutant NSCLC characterized with unique genetic Features: Clinical response and acquired resistance to the third-generation EGFR-TKIs treatment
3天前
已完结
EGFR-mutated non-small cell lung cancer
4天前
求助中
Impact of EGFR Exon 19 Deletion Subtypes on Clinical Outcomes in EGFR-TKI-Treated Advanced Non-Small-Cell Lung Cancer
1个月前
已完结
皖公网安备34019202002308
